550 related articles for article (PubMed ID: 10200014)
1. The human recombinant histamine releasing factor: functional evidence that it does not bind to the IgE molecule.
Wantke F; MacGlashan DW; Langdon JM; MacDonald SM
J Allergy Clin Immunol; 1999 Apr; 103(4):642-8. PubMed ID: 10200014
[TBL] [Abstract][Full Text] [Related]
2. Pharmacologic regulation of histamine release by the human recombinant histamine-releasing factor.
Bheekha-Escura R; Chance SR; Langdon JM; MacGlashan DW; MacDonald SM
J Allergy Clin Immunol; 1999 May; 103(5 Pt 1):937-43. PubMed ID: 10329832
[TBL] [Abstract][Full Text] [Related]
3. Recombinant histamine-releasing factor enhances IgE-dependent IL-4 and IL-13 secretion by human basophils.
Schroeder JT; Lichtenstein LM; MacDonald SM
J Immunol; 1997 Jul; 159(1):447-52. PubMed ID: 9200485
[TBL] [Abstract][Full Text] [Related]
4. Human recombinant histamine-releasing factor activates human eosinophils and the eosinophilic cell line, AML14-3D10.
Bheekha-Escura R; MacGlashan DW; Langdon JM; MacDonald SM
Blood; 2000 Sep; 96(6):2191-8. PubMed ID: 10979965
[TBL] [Abstract][Full Text] [Related]
5. Neutrophils and mast cells. Comparison of neutrophil-derived histamine-releasing activity with other histamine-releasing factors.
White MV; Kaplan AP; Haak-Frendscho M; Kaliner M
J Immunol; 1988 Nov; 141(10):3575-83. PubMed ID: 2460539
[TBL] [Abstract][Full Text] [Related]
6. Src homology 2 domain-containing inositol 5' phosphatase is negatively associated with histamine release to human recombinant histamine-releasing factor in human basophils.
Vonakis BM; Gibbons S; Sora R; Langdon JM; MacDonald SM
J Allergy Clin Immunol; 2001 Nov; 108(5):822-31. PubMed ID: 11692111
[TBL] [Abstract][Full Text] [Related]
7. Human recombinant histamine-releasing factor.
MacDonald SM
Int Arch Allergy Immunol; 1997; 113(1-3):187-9. PubMed ID: 9130518
[TBL] [Abstract][Full Text] [Related]
8. Recombinant human IL-1 alpha and -1 beta potentiate IgE-mediated histamine release from human basophils.
Massey WA; Randall TC; Kagey-Sobotka A; Warner JA; MacDonald SM; Gillis S; Allison AC; Lichtenstein LM
J Immunol; 1989 Sep; 143(6):1875-80. PubMed ID: 2476485
[TBL] [Abstract][Full Text] [Related]
9. Anti-human IgG causes basophil histamine release by acting on IgG-IgE complexes bound to IgE receptors.
Lichtenstein LM; Kagey-Sobotka A; White JM; Hamilton RG
J Immunol; 1992 Jun; 148(12):3929-36. PubMed ID: 1376345
[TBL] [Abstract][Full Text] [Related]
10. Dissociation of IgE from receptors on human basophils. I. Enhanced passive sensitization for histamine release.
Pruzansky JJ; Grammer LC; Patterson R; Roberts M
J Immunol; 1983 Oct; 131(4):1949-53. PubMed ID: 6194222
[TBL] [Abstract][Full Text] [Related]
11. Comparison of mechanisms of IL-3 induced histamine release and IL-3 priming effect on human basophils.
Okayama Y; Begishvili TB; Church MK
Clin Exp Allergy; 1993 Nov; 23(11):901-10. PubMed ID: 10779277
[TBL] [Abstract][Full Text] [Related]
12. Comparative ultrastructural morphology of human basophils stimulated to release histamine by anti-IgE, recombinant IgE-dependent histamine-releasing factor, or monocyte chemotactic protein-1.
Dvorak AM; Schroeder JT; MacGlashan DW; Bryan KP; Morgan ES; Lichtenstein LM; MacDonald SM
J Allergy Clin Immunol; 1996 Aug; 98(2):355-70. PubMed ID: 8757213
[TBL] [Abstract][Full Text] [Related]
13. Inhibition of antigen-induced mediator release from IgE-sensitized cells by a monoclonal anti-Fc epsilon RI alpha-chain receptor antibody: implications for the involvement of the membrane-proximal alpha-chain region in Fc epsilon RI-mediated cell activation.
Nechansky A; Robertson MW; Albrecht BA; Apgar JR; Kricek F
J Immunol; 2001 May; 166(10):5979-90. PubMed ID: 11342613
[TBL] [Abstract][Full Text] [Related]
14. Histamine releasing lymphokine: preliminary evidence of membrane receptors on basophils.
Ezeamuzie IC; Assem ES
Agents Actions; 1985 Dec; 17(2):131-7. PubMed ID: 2420159
[TBL] [Abstract][Full Text] [Related]
15. The effect of a naphthalene derivative, TEI-6472, on histamine release and tyrosine phosphorylation in rat basophilic leukemia cells.
Miyamoto H; Matsui K; Arai T
Int J Immunopharmacol; 1995 May; 17(5):433-41. PubMed ID: 7591368
[TBL] [Abstract][Full Text] [Related]
16. Recombinant IL-3 induces histamine release from human basophils.
MacDonald SM; Schleimer RP; Kagey-Sobotka A; Gillis S; Lichtenstein LM
J Immunol; 1989 May; 142(10):3527-32. PubMed ID: 2469718
[TBL] [Abstract][Full Text] [Related]
17. In vitro inhibition, by loratadine and descarboxyethoxyloratadine, of histamine release from human basophils, and of histamine release and intracellular calcium fluxes in rat basophilic leukemia cells (RBL-2H3).
Berthon B; Taudou G; Combettes L; Czarléwski W; Carmi-Leroy A; Marchand F; Weyer A
Biochem Pharmacol; 1994 Mar; 47(5):789-94. PubMed ID: 7510965
[TBL] [Abstract][Full Text] [Related]
18. Characterization of histamine-releasing activity: role of cytokines and IgE heterogeneity.
Liao TN; Hsieh KH
J Clin Immunol; 1992 Jul; 12(4):248-58. PubMed ID: 1380965
[TBL] [Abstract][Full Text] [Related]
19. Human neutrophil-derived histamine-releasing activity (HRA-N) causes the release of serotonin but not arachidonic acid metabolites from rat basophilic leukemia cells.
Igarashi Y; Lundgren JD; Doerfler ME; Shelhamer JH; Kaliner MA; White MV
J Allergy Clin Immunol; 1992 Jun; 89(6):1085-97. PubMed ID: 1376734
[TBL] [Abstract][Full Text] [Related]
20. Lectins do not distinguish between heterogenous IgE molecules as defined by differential activity of an IgE-dependent histamine releasing factor.
Kleine-Tebbe J; Kagey-Sobotka A; MacGlashan DW; Lichtenstein LM; MacDonald SM
J Allergy Clin Immunol; 1996 Jul; 98(1):181-8. PubMed ID: 8765833
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
